XML 56 R42.htm IDEA: XBRL DOCUMENT
v3.25.0.1

License and Collaboration Agreements - Additional Information (Details) - License Agreement - Shanghai Jemincare Pharmaceutical Co., Ltd. $ in Millions | Dec. 31, 2024 USD ($)
--- | ---
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Upfront license fee | $ 35.0
Contingent payments upon completion of manufacturing technology transfer | 1.5
Accrued upfront license fee | 35.0
Maximum |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Additional milestone payments | 672.5
Contingent payments upon achievement of specified development and regulatory milestones | 226.0
Contingent payments upon achievement of specified commercial milestones | $ 445.0

X
- Definition Accrued upfront license fee. + References No definition available. + Details
Name: | rapt_AccruedUpfrontLicenseFee
Namespace Prefix: | rapt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Additional milestone payment. + References No definition available. + Details
Name: | rapt_AdditionalMilestonePayment
Namespace Prefix: | rapt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Contingent payments upon achievement of specified commercial milestone. + References No definition available. + Details
Name: | rapt_ContingentPaymentsUponAchievementOfSpecifiedCommercialMilestone
Namespace Prefix: | rapt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Contingent payments upon achievement of specified development and regulatory milestone. + References No definition available. + Details
Name: | rapt_ContingentPaymentsUponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestone
Namespace Prefix: | rapt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Contingent payments upon completion of manufacturing technology transfer. + References No definition available. + Details
Name: | rapt_ContingentPaymentsUponCompletionOfManufacturingTechnologyTransfer
Namespace Prefix: | rapt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Upfront license fee. + References No definition available. + Details
Name: | rapt_UpfrontLicenseFee
Namespace Prefix: | rapt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=rapt_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=rapt_ShanghaiJemincarePharmaceuticalCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |